Loading
Loading
Tissue Repair & Recovery · 40mg
Choose dose
Janoshik-tested · 10 vials per kit
BPC-157 is a 15-amino-acid synthetic peptide (Body Protection Compound 157) studied in preclinical research for its multi-faceted biological activities. Research has examined its potential to support tissue repair by accelerating skin, tendon, and ligament healing via angiogenesis and endothelial cell modulation; neuroprotection through serotonin/dopamine pathway regulation; gastrointestinal support via mucosal integrity and anti-inflammatory effects; and liver protection with anti-fibrotic and cytoprotective properties.
≥98%
Purity
Lyophilised
Format
2–3 wks
Arrival
Don't want to wait 3 weeks?
Check local stock — weekday same/next-day delivery available.
Chemical Properties
Need to work out your dose?
Use our reconstitution calculator — syringe units in seconds.
Research Use Only — Disclaimer
This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.
BPC-157
Body Protection Compound 157
BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a sequence within a protective protein found in gastric juice. First described in the 1990s by researchers at the University of Zagreb, it has been studied across a broad range of preclinical models for regenerative and cytoprotective properties. Unlike many peptides it appears stable in both aqueous solution and gastric acid, facilitating study across multiple administration routes.
BPC-157 modulates multiple signalling pathways relevant to tissue repair. It upregulates VEGFR2 and promotes angiogenesis — the formation of new blood vessels required for healing. It also activates the FAK-paxillin pathway, which governs cytoskeletal organisation and cell migration. Additionally, BPC-157 influences nitric oxide (NO) synthesis and interacts with dopaminergic and serotonergic systems, which may account for its gastrointestinal and neuroprotective observations.
Preclinical studies have explored BPC-157 in models of tendon and ligament injury, gut barrier dysfunction, gastric ulceration, bone fracture healing, peripheral nerve repair, and anti-inflammatory activity. It has been co-studied with TB-500 (Thymosin Beta-4) in blended formulations for tissue recovery models. All published data to date is in animal or in vitro models; no human clinical trials have been published.
Key References
For research reference only. All information pertains to preclinical or published human trial data. Not intended as medical advice. This product is for research use only.
Don't have supplies? Grab them while you're here.
